PuriCore PLC (LON:PURI) has been reiterated to Corporate in a statement by N+1 Singer earlier today.
- Updated: September 19, 2016
N+1 Singer has reiterated PuriCore PLC(LON:PURI) to Corporate in a statement released on Tuesday September 20 2016.
Showing a price of 25.50GBX, PuriCore PLC (LON:PURI) traded 20.58% higher on the day. The last stock price is up 10.05% relative to the two hundred day average, compared to the S&P 500 which has decreased -0.01% over the same time. The company has registered a 50-day average of 20.60GBX and 200-day average of 22.74GBX. 176,686 shares of PURI exchanged hands, up from ann avg. trading volume of 4,283
Recent Performance Graphic:
With a total market value of 0.0 GBX, PuriCore PLC has a PE of 0 with a one-year low of 16.90GBX and a one-year high of 28.78GBX.
Brief Synopsis On PuriCore PLC (LON:PURI)
PuriCore Plc is a biopharmaceutical company engaged in leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company is also engaged in development of small molecule therapies in inflammatory diseases with application in dermatology, ophthalmology and rare diseases, and also for applicability across various other diseases. The Company operates through two segments: Supermarket Retail and Health Sciences. It serves the Supermarket Retail sector and Wound Care market with various technologies and formulations based on its hypochlorous acid technology. In Supermarket Retail segment, the products are used by supermarket retailers across the United States and Canada to manage freshness of fruits, vegetables and flower displays. In Health Sciences segment, the Company offers a Wound Care solution for cleansing, debriding and moisturizing chronic and acute wounds, and including diabetic ulcers and burns.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.